ZAP70 and B-cell chronic lymphocytic leukemia: In support, the presence of adverse factors such as IGHV unmutated status or expression of CD38 or ZAP-70 was shown to be associated with increased responsiveness of CLL cells to CCR7 ligands in both chemotactic and TEM assays (38, 47, 60, 66, 67).